Robotic Knee Orthosis-assisted Walking in CP
Key facts
- Who runs it
- Hospital for Special Surgery, New York
- Where
- New York, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 10 people enrolled
- Started
- 10 Feb 2025
- Ended
- 25 Apr 2026
- Type of study
- Interventional
- Treatments tested
- RKO-assisted walking in individuals with CP
- Record updated
- 18 June 2026
Who can take part
- Age
- 8 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Diagnosed with cerebral palsy at GMFCS levels I and II
- Exhibits crouch gait
- Between 8 to 65 years of age
- Hip flexion contracture less than 10 degrees
- Knee flexion contracture less than 20 degrees when measured in prone with hips extended
- Thigh-foot angle is between 15 degrees (internal) to 30 degrees (external) in prone
- Can walk a minimum distance of 10 meters without stopping
Who cannot take part
- Inability to participate in the study because of recent orthopedic surgery (within twelve months)
- No other neurological, musculoskeletal, or cardiorespiratory health conditions or injuries
- The presence of any cognitive impairment that could limit the ability to understand, follow simple directions, and inform when in pain
Where in United States
- Hospital for Special SurgeryNew York, United StatesNo longer taking part
About the trial
What the trial wants to find out
Robotic exoskeletons are becoming increasingly accepted to provide upright mobility in individuals with neurological disorders. These devices can assist in overcoming gravitational forces and reduce energy consumption. Agilik is one such device intended for individuals with neurological disorders. However, Agilik is relatively new, and its efficacy in individuals with CP is unknown. Therefore, this study aims to assess the effectiveness of Agilik as an assistive device for individuals with CP and crouch gait. In this pilot study, ten individuals with CP, GMFCS levels I and II, and crouch gait will walk with Agilik under the supervision of a physical therapist. Assessments of walking with shoes or AFO and Agilik will evaluate the efficacy of the device. The pilot study will assess if Agilik decreases crouch and improves gait characteristics in individuals with CP.
The group in the trial
- Effect of a powered knee orthosis in individuals with Cerebral Palsy and Flexed-knee GaitTreatment being tested
Treatment: RKO-assisted walking in individuals with CP
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Pilot Study to Examine the Effect of a Powered Knee Orthosis on Crouch Gait in Cerebral Palsy
- Record updated
- 18 June 2026